NCT04335084: A trial that was reported late by ProgenaBiome
This trial has reported, although it was 750 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT04335084 |
|---|---|
| Title | A Randomized, Double-Blind, Placebo-Controlled Phase IIa Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | June 22, 2020 |
| Completion date | May 31, 2022 |
| Required reporting date | May 31, 2023, midnight |
| Actual reporting date | June 19, 2025 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 750 |